Last updated on May 2018

Safety Tolerability PK and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides

Brief description of study

The purpose is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of IONIS APOC-III-LRx given to healthy volunteer subjects.

Clinical Study Identifier: NCT02900027

Contact Investigators or Research Sites near you

Start Over

Dara Bacanek

BioPharma Services
Toronto, ON Canada